Clinical Study

A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study To Evaluate Efficacy And Safety Of Dcvac/Pca Versus Placebo In Men With Metastatic Castration Resistant Prostate Cancer Eligible For 1St Line Chemotherapy

Posted Date: Jul 8, 2017

  • Investigator: Nagla Abdel Karim
  • Co-Investigator: Nicky Kurtzweil
  • Specialties: Hematology/Oncology, Prostate Cancer, Oncology, Cancer
  • Type of Study: Drug

The main purpose of this study is to find out if the study drug given with standard of care chemotherapy makes people with prostate cancer live longer than giving the standard of care chemotherapy and a placebo. The investigators also hope to learn about how long it takes for the tumor to progress, good and/or bad changes to pain levels and any good and/or bad changes to daily activities.


To Be Eligible For This Study, Patients Must Have Advanced Cancer Of The Prostate For Which The Doctor Has Recommended Treatment With Standard Of Care Chemotherapy (Docetaxel And Prednisone).


Sp005, Prostate, Castrate-Resistant , Cancer, Metastatic

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.